United States · FDA National Drug Code directory
Daptomycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-147_f9aa5759-84d0-be13-e053-6294a90af8c3
- Product NDC
- 72603-147
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Daptomycin
- Labeler
- NorthStar RxLLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230418
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPTOMYCIN — 350 mg/7mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-147-01) / 7 mL in 1 VIAL, SINGLE-DOSE · 72603-147-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →